Masimo (MASI) Competitors $171.34 +2.33 (+1.38%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$171.34 0.00 (0.00%) As of 07/2/2025 04:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MASI vs. DXCM, STE, PODD, BAX, HOLX, GMED, TFX, ITGR, ATEC, and ATRCShould you be buying Masimo stock or one of its competitors? The main competitors of Masimo include DexCom (DXCM), STERIS (STE), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Globus Medical (GMED), Teleflex (TFX), Integer (ITGR), Alphatec (ATEC), and AtriCure (ATRC). These companies are all part of the "health care equipment" industry. Masimo vs. Its Competitors DexCom STERIS Insulet Baxter International Hologic Globus Medical Teleflex Integer Alphatec AtriCure Masimo (NASDAQ:MASI) and DexCom (NASDAQ:DXCM) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, media sentiment, dividends, profitability and risk. Is MASI or DXCM more profitable? DexCom has a net margin of 12.90% compared to Masimo's net margin of -25.06%. DexCom's return on equity of 30.05% beat Masimo's return on equity.Company Net Margins Return on Equity Return on Assets Masimo-25.06% 22.56% 10.00% DexCom 12.90%30.05%10.00% Do insiders & institutionals have more ownership in MASI or DXCM? 86.0% of Masimo shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 9.7% of Masimo shares are held by company insiders. Comparatively, 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has preferable earnings and valuation, MASI or DXCM? DexCom has higher revenue and earnings than Masimo. Masimo is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMasimo$2.09B4.44-$304.90M-$9.17-18.68DexCom$4.03B8.13$576.20M$1.3462.37 Which has more risk and volatility, MASI or DXCM? Masimo has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, DexCom has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500. Do analysts prefer MASI or DXCM? Masimo currently has a consensus price target of $191.60, suggesting a potential upside of 11.82%. DexCom has a consensus price target of $98.50, suggesting a potential upside of 17.85%. Given DexCom's stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than Masimo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Masimo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83DexCom 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 3 Strong Buy rating(s) 2.95 Does the media refer more to MASI or DXCM? In the previous week, DexCom had 21 more articles in the media than Masimo. MarketBeat recorded 28 mentions for DexCom and 7 mentions for Masimo. DexCom's average media sentiment score of 1.10 beat Masimo's score of 0.80 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Masimo 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 18 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDexCom beats Masimo on 15 of the 16 factors compared between the two stocks. Get Masimo News Delivered to You Automatically Sign up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MASI vs. The Competition Export to ExcelMetricMasimoMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.16B$6.89B$5.54B$8.87BDividend YieldN/A1.16%5.39%4.10%P/E Ratio-18.6826.5426.1919.90Price / Sales4.4495.96414.04113.66Price / Cash26.4621.0136.1356.90Price / Book8.794.718.025.38Net Income-$304.90M$173.18M$3.15B$248.50M7 Day Performance2.78%1.27%1.48%2.06%1 Month Performance4.58%-0.32%3.67%4.86%1 Year Performance50.07%25.79%34.68%20.24% Masimo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MASIMasimo4.2186 of 5 stars$171.34+1.4%$191.60+11.8%+51.1%$9.16B$2.09B-18.685,600DXCMDexCom4.9226 of 5 stars$79.84-0.2%$98.50+23.4%-25.7%$31.31B$4.03B59.5810,300Positive NewsInsider TradeSTESTERIS4.9123 of 5 stars$236.95+0.5%$263.83+11.3%+9.0%$23.31B$5.46B38.2217,787Positive NewsPODDInsulet4.2191 of 5 stars$307.67+1.5%$321.00+4.3%+53.0%$21.65B$2.07B55.343,900Positive NewsBAXBaxter International4.1874 of 5 stars$30.01+0.1%$37.25+24.1%-5.3%$15.40B$10.64B-27.2838,000HOLXHologic4.7805 of 5 stars$64.43-0.1%$77.42+20.2%-11.2%$14.36B$4.03B27.197,063Positive NewsGMEDGlobus Medical4.9536 of 5 stars$57.82-0.1%$94.00+62.6%-11.1%$7.83B$2.52B43.155,300Analyst RevisionTFXTeleflex4.6863 of 5 stars$118.12-0.2%$164.63+39.4%-42.5%$5.22B$3.05B37.2614,100ITGRInteger3.598 of 5 stars$119.06+1.1%$145.00+21.8%+4.8%$4.15B$1.72B56.4311,000ATECAlphatec4.2504 of 5 stars$10.86-0.7%$17.89+64.7%+10.7%$1.59B$611.56M-9.44700ATRCAtriCure3.5607 of 5 stars$31.90+1.6%$50.67+58.8%+40.2%$1.58B$465.31M-39.381,300News CoveragePositive News Related Companies and Tools Related Companies DexCom Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Hologic Alternatives Globus Medical Alternatives Teleflex Alternatives Integer Alternatives Alphatec Alternatives AtriCure Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MASI) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Masimo Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Masimo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
